Changsheng Bio-technology faces possible delisting after regulators said it had falsified data for its rabies vaccines. Photo: Imaginechina

Embattled Chinese vaccine maker Changsheng Bio-technology risks delisting as big shareholders are barred from selling shares

Topic |   China stock market

TOP PICKS

Changsheng Bio-technology faces possible delisting after regulators said it had falsified data for its rabies vaccines. Photo: Imaginechina
READ FULL ARTICLE